Valuation : Illumina, Inc.

Market Cap 33.95B 29.14B 27.29B 24.98B 47.02B 3,243B 47.2B 323B 126B 1,622B 127B 125B 5,410B P/E 2026 *
45.4x
P/E 2027 * 38.4x
Enterprise Value 34.2B 29.35B 27.48B 25.16B 47.36B 3,267B 47.54B 325B 127B 1,634B 128B 126B 5,450B EV / Sales 2026 *
7.39x
EV / Sales 2027 * 6.76x
Free-Float
74.98%
Yield 2026 *
-
Yield 2027 * -
1 day+1.27%
1 week+11.07%
Current month+11.01%
1 month+17.31%
3 months+56.78%
6 months+78.72%
Current year+73.60%
1 week 208.5
Extreme 208.5
231.81
1 month 186.64
Extreme 186.64
231.81
Current year 112.65
Extreme 112.65
231.81
1 year 88
Extreme 88
231.81
3 years 68.7
Extreme 68.7
231.81
5 years 68.7
Extreme 68.7
471.1
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 24/09/2023
Director of Finance/CFO 50 14/04/2024
Chief Tech/Sci/R&D Officer 55 28/05/2025
Director TitleAgeSince
Director/Board Member 65 27/07/2016
Director/Board Member 66 31/12/2016
Director/Board Member 65 04/02/2019
Date Insider Type Main position Quantity % Market Cap.
21/08/26
Corvex Management LP
SellCompany -299,336 0.1978%
19/08/26 Other

Director

0 0%
18/08/26 Sell

Executive/Senior Manager

-1,033 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
+1.27%+11.07%+130.62%+44.03% 33.95B
-0.47%+2.80%+29.11%+16.45% 234B
+0.15%+1.98%+4.57%-15.60% 151B
-0.90%-7.71%-22.60%+23.36% 131B
-3.11%-10.27%-56.13%-8.06% 69.81B
-0.91%-2.52%+10.68%+18.09% 52.33B
0.00%-1.80%-16.89%-13.58% 50.91B
+1.68%+1.47%+33.30%+31.76% 43.8B
+1.71%+1.30%+42.25%+54.10% 40.69B
+0.03%+2.22%-17.33%+46.45% 34B
Average +0.41%+1.00%+13.76%+19.70% 84.21B
Weighted average by Cap. +0.14%+0.35%+8.74%+12.96%

Financials

2026 *2027 *
Net sales 4.62B 3.97B 3.72B 3.4B 6.41B 442B 6.43B 43.96B 17.18B 221B 17.36B 16.99B 737B 4.91B 4.21B 3.95B 3.61B 6.8B 469B 6.83B 46.68B 18.25B 235B 18.44B 18.04B 783B
Net income 760M 652M 611M 559M 1.05B 72.64B 1.06B 7.23B 2.82B 36.33B 2.85B 2.79B 121B 891M 765M 716M 656M 1.23B 85.14B 1.24B 8.47B 3.31B 42.58B 3.35B 3.27B 142B
Net Debt 246M 211M 198M 181M 341M 23.5B 342M 2.34B 914M 11.75B 924M 904M 39.21B -729M -626M -586M -536M -1.01B -69.64B -1.01B -6.93B -2.71B -34.83B -2.74B -2.68B -116B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
27/08/26 US$227.69 +1.27% 1,926,094
26/08/26 US$224.84 -0.07% 1,714,494
25/08/26 US$224.99 +0.79% 1,918,113
24/08/26 US$223.22 +1.74% 2,250,988
21/08/26 US$219.40 +2.89% 1,917,222
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
224.84USD
Average target price
198.89USD
Spread / Average Target
-11.54%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock